Holen Sie sich die Stockscreener-App
206.76
0.06%
-0.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RMD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Resmed Inc Aktie (RMD) Neueste Nachrichten
ResMed Inc stock (AU000000RMD6): Sleep apnea and respiratory care leader posts strong growth outlook - AD HOC NEWS
ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend - Yahoo Finance
Should you continue to hold Resmed stock in your portfolio? - MSN
ResMed Inc. stock: Earnings beat but shares slip on guidance concerns - AD HOC NEWS
Number of shareholders of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – LSX:935168 - TradingView
ResMed, Inc. Experiences Valuation Adjustment Amid Competitive Pharmaceuticals Sector Landscape - Markets Mojo
Mitsubishi UFJ Asset Management Co. Ltd. Increases Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Sold by Strs Ohio - MarketBeat
ResMed expects FY 2026 gross margin of 62%-63% as it plans $175M+ Q4 buybacks and targets June 1 close for $340M Noctrix deal - MSN
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
[144] RESMED INC SEC Filing - Stock Titan
QRG Capital Management Inc. Has $5.39 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
Resmed boosts sleep health portfolio with Noctrix buy - BioWorld News
ResMed Stock Is Down 22% in 2026: Here’s Why Analysts Still Sees $256 Fair Value - TIKR.com
Piper Sandler Maintains ResMed(RMD.US) With Hold Rating, Cuts Target Price to $233 - Moomoo
Swedbank AB Has $265.55 Million Holdings in ResMed Inc. $RMD - MarketBeat
Harel Insurance Investments & Financial Services Ltd. Decreases Stock Holdings in ResMed Inc. $RMD - MarketBeat
Wall Street's insights into key metrics ahead of ResMed (RMD) Q3 earnings - MSN
ResMed, Inc. Hits New 52-Week Low at USD 210.67 - Markets Mojo
Resmed enters merger agreement to acquire Noctrix Health for $340 million - MassDevice
9 Stocks That Could Defy the ’Sell in May and Go Away’ Trend This Time - Investing.com
Resmed integrating AI for sleep apnea treatment - Yahoo Finance
Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance
Birch Capital Management LLC Reduces Stock Holdings in ResMed Inc. $RMD - MarketBeat
RMD Stock Price, Quote & Chart | RESMED INC (NYSE:RMD) - ChartMill
Stifel Nicolaus Adjusts ResMed Price Target to $235 From $265 - Moomoo
Ord Minnett Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) - The Globe and Mail
[Form 3] RESMED INC Initial Statement of Beneficial Ownership - Stock Titan
ResMed (RMD) CFO Brett Sandercock reports direct holding of 83,495 shares - Stock Titan
ResMed Inc. stock rises Monday, outperforms market - MarketWatch
ResMed Inc. (RMD) Stock Analysis: Exploring a 31.99% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ResMed (RMD) Is Down 6.7% After Earnings Beat And CFO Transition NewsWhat's Changed - Sahm
ResMed announces CFO succession - MSN
Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX - Moomoo
ResMed Price Target Cut 13% to A$41.72/Share by Morgans - Moomoo
CSL, Resmed, Cochlear Lead Losses on ASX - marketscreener.com
ResMed Price Target Cut 2% to A$46.50/Share by Macquarie - Moomoo
ResMed Updates CDI Count Amid Routine Share Transfers, Issuances and Buybacks - TipRanks
ResMed: Q3 result 2026 - intelligentinvestor.com.au
ResMed Inc. 2026 Q3ResultsEarnings Call Presentation (NYSE:RMD) 2026-05-03 - Seeking Alpha
ResMed Files March 2026 Quarterly Report Detailing Capital Structure and Compliance Status - TipRanks
ResMed (RMD) Margin Strength At 27.5% Tests Bearish Cost And GLP 1 Narratives - Sahm
ResMed Stock Fell 8% This Week. Here’s What a Strong Earnings Beat Means for the Recovery Case - TIKR.com
Why ResMed (RMD) Narrative Is Shifting As Analysts Reassess Growth And Valuation Assumptions - Yahoo Finance
Pittenger & Anderson Inc. Acquires 5,421 Shares of ResMed Inc. $RMD - MarketBeat
PFA Pension Forsikringsaktieselskab Buys Shares of 188,393 ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Stake Cut by Danske Bank A S - MarketBeat
ResMed Shifts Leadership And Adds Neurology With Noctrix Acquisition - Sahm
ResMed: Stock splutters, but machine is still breathing well - marketscreener.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Immunome (IMNM) and Resmed (RMD) - The Globe and Mail
ResMed Q3 Earnings Call Highlights - Yahoo Finance
Pictet Asset Management Holding SA Sells 42,929 Shares of ResMed Inc. $RMD - MarketBeat
ResMed stock hits 52-week low at $205.86 amid market challenges - Investing.com Nigeria
Analysts Are Bullish on These Healthcare Stocks: Merck & Company (MRK), Resmed (RMD) - The Globe and Mail
ResMed Earnings Call Highlights Margin Strength, Growth - TipRanks
ResMed Inc (RMD) Stock Down 4.1% -- Now Undervalued? GF Score: 9 - GuruFocus
ResMed Inc. stock falls Friday, underperforms market - MarketWatch
ResMed on Track for Lowest Close Since July 2024 -- Data Talk - Moomoo
Research Alert: CFRA Lowers Rating On Shares Of Resmed Inc. To Sell From Hold - Moomoo
Royal Bank Of Canada Forecasts Strong Price Appreciation for ResMed (NYSE:RMD) Stock - MarketBeat
ResMed Q3 2026 earnings preview - MSN
ResMed (NYSE:RMD) Shares Down 6% on Analyst Downgrade - MarketBeat
2.07%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):